FI870580A - Saosom kardiovaskulaera laekemedel anvaendbara 3-alkoxi-2-aminopropylaminer. - Google Patents

Saosom kardiovaskulaera laekemedel anvaendbara 3-alkoxi-2-aminopropylaminer. Download PDF

Info

Publication number
FI870580A
FI870580A FI870580A FI870580A FI870580A FI 870580 A FI870580 A FI 870580A FI 870580 A FI870580 A FI 870580A FI 870580 A FI870580 A FI 870580A FI 870580 A FI870580 A FI 870580A
Authority
FI
Finland
Prior art keywords
aminopropylaminer
saosom
anvaendbara
alcoxi
cardiovascular
Prior art date
Application number
FI870580A
Other languages
English (en)
Finnish (fi)
Other versions
FI870580A0 (fi
Inventor
Philip Paul Grous
Richard Joseph Mohrbacher
Original Assignee
Mcneilab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mcneilab Inc filed Critical Mcneilab Inc
Publication of FI870580A0 publication Critical patent/FI870580A0/fi
Publication of FI870580A publication Critical patent/FI870580A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/40—Acylated substituent nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Furan Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI870580A 1986-02-12 1987-02-11 Saosom kardiovaskulaera laekemedel anvaendbara 3-alkoxi-2-aminopropylaminer. FI870580A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/828,923 US4727072A (en) 1986-02-12 1986-02-12 3-alkoxy-2-aminopropylamines compositions and use as cardiovascular agents

Publications (2)

Publication Number Publication Date
FI870580A0 FI870580A0 (fi) 1987-02-11
FI870580A true FI870580A (fi) 1987-08-13

Family

ID=25253093

Family Applications (1)

Application Number Title Priority Date Filing Date
FI870580A FI870580A (fi) 1986-02-12 1987-02-11 Saosom kardiovaskulaera laekemedel anvaendbara 3-alkoxi-2-aminopropylaminer.

Country Status (12)

Country Link
US (1) US4727072A (zh)
EP (1) EP0237191A1 (zh)
JP (1) JPS62215577A (zh)
KR (1) KR870007882A (zh)
CN (1) CN87100686A (zh)
AU (2) AU599954B2 (zh)
DK (1) DK69987A (zh)
FI (1) FI870580A (zh)
HU (1) HU198032B (zh)
NO (1) NO169069C (zh)
NZ (1) NZ219161A (zh)
ZA (1) ZA87988B (zh)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4727072A (en) * 1986-02-12 1988-02-23 Mcneilab, Inc. 3-alkoxy-2-aminopropylamines compositions and use as cardiovascular agents
DE3726632A1 (de) * 1987-08-11 1989-05-18 Boehringer Mannheim Gmbh 1,2-diamino-verbindungen, verfahren zu ihrer herstellung sowie arzneimittel, die diese verbindungen enthalten
DE3726633A1 (de) * 1987-08-11 1989-02-23 Boehringer Mannheim Gmbh Neue 1,2-diamino-verbindungen, verfahren zu ihrer herstellung sowie arzneimittel, die diese verbindungen enthalten
US4888335A (en) * 1988-07-25 1989-12-19 Mcneilab, Inc. 3-alkoxy-2-aminopropyl heterocyclic amines and their use as cardiovascular agents
US5185362A (en) * 1988-09-14 1993-02-09 Mcneilab, Inc. Diphenylamine cardiovascular agents, compositions and use
EP0507488A1 (en) * 1991-03-27 1992-10-07 Merck & Co. Inc. Inhibitors of HIV-1 reverse transcriptase
DE60234057D1 (de) 2001-07-25 2009-11-26 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
CN103259027A (zh) 2005-04-28 2013-08-21 普罗透斯数字保健公司 药物信息系统
KR20090071598A (ko) 2006-09-18 2009-07-01 랩터 파마슈티컬 인코포레이티드 수용체 결합 단백질(ｒａｐ)-접합체 투여에 의한 간 질환의 치료
PT2398500T (pt) 2009-02-20 2019-06-14 2 Bbb Medicines B V Sistema de entrega de medicamentos à base de glutationas
TWI556839B (zh) 2009-05-06 2016-11-11 研究室護膚股份有限公司 包含活性劑－磷酸鈣粒子複合物之皮膚遞送組成物及其使用方法
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US30577A (en) * 1860-11-06 Truss-bridge
BE795735A (fr) * 1972-03-06 1973-06-18 Cerm Cent Europ Rech Mauvernay Nouvelles ethylenediamines substituees a activite cardiovasculaire
US4430338A (en) * 1980-09-30 1984-02-07 Akzo N.V. Method of treatment patients at risk of sudden death
NO149468C (no) * 1981-07-17 1984-04-25 Vefi As Rykkegrep.
DK156396C (da) * 1983-09-27 1990-01-08 Cerm Cent Europ Rech Mauvernay 2-(n-pyrrolidino)-3-isobutoxy-n-substituerede phenyl-n-benzyl-propylamin-forbindelser og farmaceutiske midler indeholdende disse
GB8330197D0 (en) * 1983-11-11 1983-12-21 Akzo Nv Ether of n-propanolamine derivative
DE3468684D1 (de) * 1983-11-11 1988-02-18 Akzo Nv Ether of n-propanolamine derivative
FR2558161B1 (fr) * 1984-01-18 1987-01-23 Cerm Cent Europ Rech Mauvernay 3-alkoxy 2-(n-pyrrolidino) n-furylmethyl ou n-thienylmethyl n-pyridyl propylamines, leur preparation et leur application en therapeutique
US4727072A (en) * 1986-02-12 1988-02-23 Mcneilab, Inc. 3-alkoxy-2-aminopropylamines compositions and use as cardiovascular agents

Also Published As

Publication number Publication date
AU599954B2 (en) 1990-08-02
JPS62215577A (ja) 1987-09-22
NO169069C (no) 1992-05-06
ZA87988B (en) 1988-09-28
NO870533L (no) 1987-08-13
NO870533D0 (no) 1987-02-11
CN87100686A (zh) 1987-10-14
NZ219161A (en) 1989-03-29
HUT46660A (en) 1988-11-28
HU198032B (en) 1989-07-28
US4727072A (en) 1988-02-23
AU621003B2 (en) 1992-02-27
FI870580A0 (fi) 1987-02-11
EP0237191A1 (en) 1987-09-16
DK69987A (da) 1987-08-13
NO169069B (no) 1992-01-27
AU6868087A (en) 1987-08-13
AU5988990A (en) 1990-11-15
DK69987D0 (da) 1987-02-11
KR870007882A (ko) 1987-09-22

Similar Documents

Publication Publication Date Title
DE3764993D1 (de) Deckenbauweise.
FI871039A0 (fi) Foerfarande foer bestaemmande av endoglykosidasaktivitet.
FI875342A (fi) Foerfarande foer mekanisk-termisk avvattning av en fibermaterialbana.
FI873132A0 (fi) Foerbaettring foer bombering av glasskivor.
NO874179D0 (no) Sammenleggbar oppbygging.
FI863861A0 (fi) Foerfarande foer koordinering av hissgrupper.
FI77063B (fi) Foerfarande foer effektivering av fibersuspensionstvaett.
FI871478A0 (fi) Kopplingsanordning foer skyddande av en foerbrukare fraon oeverspaenningar.
FI875457A0 (fi) Skarvning av dukars aendor.
FI873654A0 (fi) Maetning av arkmaterial innehaollande fuktskikt.
FI891309A0 (fi) Hoegtryck- och hoegtemperaturpolymerisering av etylen.
FI82029B (fi) Anordning foer vaermehaerdning av glasskivor.
FI872515A0 (fi) Foerfarande foer acylering av aromatiska foereningar.
FI870580A0 (fi) Saosom kardiovaskulaera laekemedel anvaendbara 3-alkoxi-2-aminopropylaminer.
ES2023141B3 (es) Algunas 3-benzoil-4-oxolactamas.
FI852221L (fi) Saosom kardiovaskulaera laekemedel anvaendbara dihydropyridiner.
FI870722A (fi) Bestrykningsanordning foer belaeggning av en varubana.
FI875058A0 (fi) Anordning foer loesgoerbart faestande av en skidsko.
DE3774371D1 (de) Baueinheit.
FI870867A (fi) Foerfarande foer framstaellning av kontinuerligt tillvaexande primaerceller.
FI870117A (fi) Bestraolningsanordning av solenergi foer medicinskt bruk.
FI874289A0 (fi) Foerfarande foer framstaellning av traemassa.
FI873770A0 (fi) Vaotpress foer avvattning av fiberbanor.
FI864971A0 (fi) Foerfarande foer framstaellning av vaeteperoxid.
FI875452A (fi) Foerfarande foer framstaellning av mercaptobenzoater.

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: MCNEILAB, INC.